Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$1.32 - $2.12 $9,224 - $14,814
-6,988 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$1.69 - $5.81 $779 - $2,678
461 Added 7.06%
6,988 $12,000
Q4 2021

Feb 11, 2022

SELL
$4.09 - $8.67 $797 - $1,690
-195 Reduced 2.9%
6,527 $35,000
Q3 2021

Nov 12, 2021

SELL
$6.6 - $12.78 $1,056 - $2,044
-160 Reduced 2.32%
6,722 $55,000
Q2 2021

Aug 13, 2021

BUY
$12.14 - $20.35 $62,059 - $104,029
5,112 Added 288.81%
6,882 $91,000
Q1 2021

May 07, 2021

BUY
$16.87 - $31.21 $388 - $717
23 Added 1.32%
1,770 $36,000
Q4 2020

Feb 12, 2021

BUY
$10.89 - $20.16 $19,024 - $35,219
1,747 New
1,747 $35,000

Others Institutions Holding BDSX

About BIODESIX INC


  • Ticker BDSX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 39,982,000
  • Market Cap $54M
  • Description
  • Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...
More about BDSX
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.